Recent progress in research on beta-cell apoptosis by cytokines

被引:39
|
作者
Kim, Kyoung-Ah [2 ]
Lee, Myung-Shik [1 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul 135710, South Korea
[2] Dongguk Univ, Sch Med, Int Hosp, Dept Med, Goyang, South Korea
来源
关键词
Apoptosis; Diabetes; XIAP; NF-kappaB; TNF-alpha; IFN-gamma; STAT1; Signal transduction; Review; NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; CD8+ T-CELLS; FACTOR-ALPHA; NITRIC-OXIDE; FAS LIGAND; IKK-BETA; INTERFERON-GAMMA; GENE-EXPRESSION; IFN-GAMMA;
D O I
10.2741/3271
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pancreatic beta-cell apoptosis plays a critical role in the pathogenesis of type 1 diabetes mellitus. As death effector molecules, perforin, Fas ligand, tumor necrosis factor (TNF)-alpha, Interleukin (IL)-1, interferon (IFN)-gamma, and nitric oxide have been claimed. Recently, combinations or synergisms between IFN-gamma and TNF-alpha or IL-1 beta are being revisited as the death effectors, and signal transduction of such synergisms has been explored to find molecular mechanism of beta-cell death. Among the regulators of apoptosis, nuclear factor-kappaB (NF-kappaB) has emerged as a master switch of cytokine-induced beta-cell dysfunction and death. By employing TNF-alpha/IFN-gamma synergism model which causes beta -cell apoptosis, we found that the antiapoptotic X-linked inhibitor of apoptosis ( XIAP) molecule is upregulated by NF-kappaB in response to TNF-alpha and XIAP induction was inhibited by IFN-gamma-induced signal transducer and activator of transcription-1 (STAT1) activation, which explains the death of beta -cells by TNF-alpha/IFN-gamma synergism.
引用
收藏
页码:657 / 664
页数:8
相关论文
共 50 条
  • [21] Beta-cell targeted gene delivery for enhanced beta-cell proliferation
    Lu, B.
    Tonne, J. M.
    Leber, S.
    Kurmi, K.
    Munoz-Gomez, M.
    Jacobus, E. J.
    Kudva, Y. C.
    Ikeda, Y.
    [J]. HUMAN GENE THERAPY, 2015, 26 (10) : A63 - A63
  • [22] Beta-cell apoptosis in the pathogenesis of human type 2 diabetes mellitus
    Leonardi, O
    Mints, G
    Hussain, MA
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2003, 149 (02) : 99 - 102
  • [23] Prolactin (rhPRL) promotes human beta-cell survival by inhibiting apoptosis
    Labriola, Leticia
    Terra, Leticia F.
    Garay-Malpartida, Miguel H.
    Mares-Guia, Thiago R.
    Sogayar, Mari C.
    [J]. XENOTRANSPLANTATION, 2009, 16 (05) : 344 - 344
  • [24] On the track to the beta-cell
    Malaisse, WJ
    [J]. DIABETOLOGIA, 2001, 44 (04) : 393 - 406
  • [25] Exenatide enhances beta-cell mass, increases beta-cell division, and decreases apoptosis but does not reverse hyperglycemia in new onset NOD mice
    Xue, S.
    Wasserfall, C. H.
    Parker, M. J.
    McGrail, K. M.
    McGrail, S. M.
    Moore, M. C.
    Brusko, T. M.
    Schatz, D. A.
    Atkinson, M. A.
    Haller, M. J.
    [J]. ACTA DIABETOLOGICA, 2007, 44 : S19 - S19
  • [26] Beta-cell replacement
    Desai, NM
    Korbutt, GS
    Barker, CF
    Lafferty, KJ
    [J]. DIABETOLOGIA, 1997, 40 (Suppl 3) : B44 - B49
  • [27] INEXHAUSTIBLE BETA-CELL
    JACKSON, WPU
    VINIK, AI
    KELLER, P
    BOTHA, JL
    [J]. SOUTH AFRICAN MEDICAL JOURNAL, 1975, 49 (13): : 477 - 477
  • [28] ARTIFICIAL BETA-CELL
    ROSMAN, MS
    JACKSON, WPU
    [J]. SOUTH AFRICAN MEDICAL JOURNAL, 1979, 56 (24): : 1018 - 1019
  • [29] On the track to the beta-cell
    W. J. Malaisse
    [J]. Diabetologia, 2001, 44 : 393 - 406
  • [30] Beta-cell replacement
    N. M. Desai
    G. S. Korbutt
    C. F. Barker
    K. J. Lafferty
    [J]. Diabetologia, 1997, 40